✦ LIBER ✦

Challenges in Clinical Design of Immunotherapy Trials for Malignant Glioma

✍ Scribed by Rolle, Cleo E.; Sengupta, Sadhak; Lesniak, Maciej S.

Book ID: 122305474
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 304 KB
Volume: 21
Category: Article
ISSN: 1042-3680
DOI: 10.1016/j.nec.2009.08.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trials of gene therapy, virothe

Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas

✍ Barzon, L; Zanusso, M; Colombo, F; Palù, G 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 213 KB

Immunotherapy for colorectal cancer:a ch

Immunotherapy for colorectal cancer:a challenge to clinical trial design

✍ Rachel Midgley; David Kerr 📂 Article 📅 2000 🏛 The Lancet 🌐 English ⚖ 861 KB

Response Assessment Challenges in Clinic

Response Assessment Challenges in Clinical Trials of Gliomas

✍ Patrick Y. Wen; Andrew D. Norden; Jan Drappatz; Eudocia Quant 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 210 KB

Chemoprevention: Challenges in design an

Chemoprevention: Challenges in design and conduct of cancer clinical trials

✍ Victor G. Vogel 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Phase 1 clinical trial of bortezomib in

Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma

✍ Surasak Phuphanich; Jeffrey G. Supko; Kathryn A. Carson; Stuart A. Grossman; L. 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 268 KB

On statistical analysis for placebo-chal

On statistical analysis for placebo-challenging designs in clinical trials

✍ Shein-Chung Chow; Jun Shao; Hsin-Tsung Ho 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

In clinical trials, appropriate designs are often chosen to address scientific/medical questions of particular interest to the investigator. For a chosen statistical design, however, standard statistical procedures may not be applicable owing to the nature of the design. In this paper we examine sta